This work suggests that the amplification of cascades involving HMGB1 may be inhibited by butyrate treatment through the TLR4/NF-κB pathway, and through this mechanism inhibited intestinal inflammation in NEC (20). Here, NFKB1 is linked to necrotizing enterocolitis.